Blog
Invitation Homes to Report Q1 Earnings: What's in Store for the Stock?
Invitation Homes INVH is slated to report first-quarter 2025 results on April 30, after market close. The company’s quarterly results are likely to display a year-over-year increase in revenues and
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings?
Amazon AMZN is scheduled to report first-quarter 2025 results on May 1.For the first quarter, net sales are expected between $151 billion and $155.5 billion. Net sales are expected to grow 5-9% from
Public Service Enterprise Set to Report Q1 Earnings: What to Expect?
Public Service Enterprise Group Incorporated PEG, or PSEG, is scheduled to report first-quarter 2025 results on April 30, before market open.The company delivered an earnings surprise of 1.20% in
Talos Energy (TALO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Talos Energy (TALO) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Stoke Therapeutics, Inc. (STOK) reports results for the quarter ended March 2025. While this widely-known consensus
Gibson Energy Inc. (GBNXF) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year decline in earnings on lower revenues when Gibson Energy Inc. (GBNXF) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy?
Hims & Hers Health, Inc. (HIMS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Earnings Preview: Interparfums (IPAR) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Interparfums (IPAR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Analysts Estimate Freshpet (FRPT) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Freshpet (FRPT) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Henry Schein (HSIC) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Coterra Energy (CTRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Coterra Energy (CTRA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Diamondback Energy (FANG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate Crescent Energy (CRGY) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Crescent Energy (CRGY) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Corebridge Financial (CRBG) Earnings Expected to Grow: Should You Buy?
Corebridge Financial (CRBG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate BWX Technologies (BWXT) to Report a Decline in Earnings: What to Look Out for
The market expects BWX Technologies (BWXT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?
Certara, Inc. (CERT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
BioCryst Pharmaceuticals (BCRX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
The Beachbody Company, Inc. (BODI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
The market expects The Beachbody Company, Inc. (BODI) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known
BellRing Brands (BRBR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when BellRing Brands (BRBR) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Freightcar America (RAIL) Earnings Expected to Grow: Should You Buy?
Freightcar America (RAIL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Ares Management (ARES) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Ares Management (ARES) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline
The market expects Axsome Therapeutics (AXSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Neurocrine Biosciences (NBIX) reports results for the quarter ended March 2025. While this widely-known
Primoris Services (PRIM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Primoris Services (PRIM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook